Response to Wang et al., "Comments on 'Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis'". Chang JW, Wang F. J Am Acad Dermatol 2025 Aug 29:S0190-9622(25)02699.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang JW, Wang F. Response to Wang et al., "Comments on 'Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis'". J Am Acad Dermatol 2025 Aug 29:S0190-9622(25)02699.
PMID: 40886840